Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DBV Technologies S.A. - American Depositary Shares (DBVT)
:DBVT
RESEARCH TOOLSreports
DBVT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.20 - $9.09
Previous CloseN/A
Volume52.91K
Average Volume (3M)103.78K
Market Cap
$86.83M
Enterprise Value$28.88M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.44
Next Earnings
Mar 06, 2025EPS Estimate
-0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.31
Shares Outstanding20,569,500
10 Day Avg. Volume11,700
30 Day Avg. Volume103,777
Standard Deviation0.28
R-Squared0.02
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.79
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market Cap0.33
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.84
Enterprise Value/Ebitda-0.29
Forecast
1Y Price Target
$10.00Price Target Upside127.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
DBV Technologies SA - American News
PremiumCompany Announcements
DBV Technologies Reports Positive Phase 3 Study Results
PremiumCompany Announcements
DBV Technologies Amends Executive Severance Agreements
PremiumCompany Announcements
DBV Technologies Aligns with FDA for Viaskin Peanut Approval
---
Bulls Say, Bears Say
Bulls Say
Commercial OpportunityViaskin Peanut's development path is largely derisked with a blockbuster commercial opportunity, especially in 1-3 year olds, where its safety and convenience will resonate with parents.
Regulatory ProgressThe FDA confirmed DBVT just needs to complete a 6-month safety study in 1-3 year olds and start a confirmatory efficacy trial by the time of its BLA submission for accelerated approval in toddlers.
Bears Say
Financial ConstraintsDBVT ended 2Q24 with $66M in cash, providing sufficient runway only into 1Q25, indicating a need for additional capital.
---
Ownership Overview
0.81% Insiders
0.02% Mutual Funds
10.88% Other Institutional Investors
88.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
DBVT FAQ
What was DBV Technologies S.A. - American Depositary Shares’s price range in the past 12 months?
DBV Technologies S.A. - American Depositary Shares lowest stock price was $2.20 and its highest was $9.09 in the past 12 months.
What is DBV Technologies S.A. - American Depositary Shares’s market cap?
DBV Technologies S.A. - American Depositary Shares’s market cap is $86.83M.
When is DBV Technologies S.A. - American Depositary Shares’s upcoming earnings report date?
DBV Technologies S.A. - American Depositary Shares’s upcoming earnings report date is Mar 06, 2025 which is in 12 days.
How were DBV Technologies S.A. - American Depositary Shares’s earnings last quarter?
DBV Technologies S.A. - American Depositary Shares released its earnings results on Nov 06, 2024. The company reported -$1.6 earnings per share for the quarter, beating the consensus estimate of -$1.8 by $0.2.
Is DBV Technologies S.A. - American Depositary Shares overvalued?
According to Wall Street analysts DBV Technologies S.A. - American Depositary Shares’s price is currently Undervalued.
Does DBV Technologies S.A. - American Depositary Shares pay dividends?
DBV Technologies S.A. - American Depositary Shares does not currently pay dividends.
What is DBV Technologies S.A. - American Depositary Shares’s EPS estimate?
DBV Technologies S.A. - American Depositary Shares’s EPS estimate is -0.22.
How many shares outstanding does DBV Technologies S.A. - American Depositary Shares have?
DBV Technologies S.A. - American Depositary Shares has 20,569,500 shares outstanding.
What happened to DBV Technologies S.A. - American Depositary Shares’s price movement after its last earnings report?
DBV Technologies S.A. - American Depositary Shares reported an EPS of -$1.6 in its last earnings report, beating expectations of -$1.8. Following the earnings report the stock price went down -3.896%.
Which hedge fund is a major shareholder of DBV Technologies S.A. - American Depositary Shares?
Currently, no hedge funds are holding shares in DBVT
---
DBV Technologies SA - American Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (127.27% Upside)
$10.00 (127.27% Upside)
Hedge Fund Trend
Decreased
By 1.0 Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-45.74%
12-Months-Change
Fundamentals
Return on Equity
-103.11%
Trailing 12-Months
Asset Growth
-50.97%
Trailing 12-Months
Company Description
DBV Technologies S.A. - American Depositary Shares
DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. It focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Montrouge, France.
---
DBVT Stock 12 Month Forecast
Average Price Target
$10.00
▲(127.27% Upside)
Technical Analysis
Arrowhead Pharmaceuticals
―
VistaGen Therapeutics
―
Seres Therapeutics
―
AnaptysBio
―
Xeris Pharmaceuticals
―
Best Analysts Covering DBVT
1 Year
1 Year Success Rate
7/25 ratings generated profit
1 Year Average Return
-23.81%
reiterated a buy rating last month
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 28.00% of your transactions generating a profit, with an average return of -23.81% per trade.
---